Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▴	Diluted EPS
AMLX	Amylyx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$144.74M	n/a	-47.4%	-100.0%	-$1.53
AZTR	Azitra, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$10.96M	n/a	-288.2%	-100.0%	-$2.25
CAPR	Capricor Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$105.04M	n/a	-34.4%	-100.0%	-$2.26
CNBX	CNBX Pharmaceuticals Inc. Manufacturing · Year ended 2025-08-31 · USD	$0	-$314.0K	n/a	n/a	-100.0%	$0.00
FULC	Fulcrum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$74.88M	n/a	-21.5%	-100.0%	-$1.18
IXHL	Incannex Healthcare Inc. Manufacturing · Year ended 2026-06-30 · USD	$0	-$19.30M	n/a	-28.6%	-100.0%	-$1.66
KPRX	Kiora Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$0	-$10.84M	n/a	-67.2%	-100.0%	-$2.64
LITS	Lite Strategy, Inc. Manufacturing · Year ended 2025-06-30 · USD	$0	-$15.95M	n/a	-94.2%	-100.0%	-$2.39
NGNE	Neurogene Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$90.35M	n/a	-34.1%	-100.0%	-$4.24
PRAX	Praxis Precision Medicines, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$303.27M	n/a	-34.5%	-100.0%	-$13.48
PTN	Palatin Technologies Inc Manufacturing · Year ended 2025-06-30 · USD	$0	-$17.31M	n/a	n/a	-100.0%	-$32.15
SPRB	Spruce Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$38.97M	n/a	-91.7%	-100.0%	-$50.83
SYBX	Synlogic, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$1.00M	n/a	-8.5%	-100.0%	-$0.08
VTVT	vTv Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$26.97M	n/a	-41.9%	-100.0%	n/a
XCUR	Exicure, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$4.95M	n/a	-126.0%	-100.0%	-$0.79
ZNTL	Zentalis Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$137.06M	n/a	-63.4%	-100.0%	-$1.91
CNTB	Connect Biopharma Holdings Ltd Manufacturing · Year ended 2025-12-31 · USD	$64.0K	-$55.48M	n/m	-132.2%	-99.8%	-$1.00
SLN	Silence Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$559.0K	-$88.61M	n/m	-142.2%	-98.7%	-$0.63
HCWB	HCW Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.2K	-$7.96M	n/m	-287.9%	-97.9%	-$10.63
ADTX	Aditxt, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.2K	-$43.10M	n/m	-768.3%	-97.6%	-$1153.83
PRTA	Prothena Corp Public Ltd Co Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$244.09M	n/m	-87.0%	-92.8%	-$4.53
RNAC	Cartesian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.80M	-$130.30M	n/m	n/a	-92.8%	-$5.02
NEUP	Neuphoria Therapeutics Inc. Manufacturing · Year ended 2026-06-30 · USD	$1.17M	-$13.45M	n/m	-54.7%	-92.5%	-$3.06
PTGX	Protagonist Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$46.02M	-$130.15M	-282.8%	-21.2%	-89.4%	-$2.05
TRDA	Entrada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.42M	-$143.75M	-565.5%	-47.0%	-87.9%	-$3.47
AVTX	Avalo Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$59.0K	-$78.26M	n/m	-94.2%	-86.6%	-$5.84
LSTA	Lisata Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.0K	-$16.59M	n/m	-111.7%	-83.0%	-$1.91
STTK	Shattuck Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.00M	-$48.81M	n/m	-59.2%	-82.5%	-$0.70
LPCN	Lipocine Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.98M	-$9.63M	-487.1%	-66.5%	-82.3%	-$1.69
IBIO	iBio, Inc. Manufacturing · Year ended 2026-06-30 · USD	$100.0K	-$33.04M	n/m	-38.6%	-75.0%	-$0.32
WHWK	Whitehawk Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.14M	-$20.60M	-288.3%	-15.1%	-72.5%	-$0.33
BTAIQ	BioXcel Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$642.0K	-$69.90M	n/m	n/a	-71.7%	-$5.73
ROIV	Roivant Sciences Ltd. Manufacturing · Year ended 2026-03-31 · USD	$8.26M	-$299.77M	n/m	-6.6%	-71.6%	-$0.54
INO	Inovio Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$65.3K	-$84.95M	n/m	-352.5%	-70.0%	-$1.81
ONCO	Onconetix, Inc. Manufacturing · Year ended 2025-12-31 · USD	$815.4K	-$14.03M	n/m	-89.0%	-67.7%	-$16.56
DNTH	Dianthus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$162.34M	n/m	-32.9%	-67.3%	-$4.20
WVE	Wave Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$42.73M	-$204.38M	-478.3%	-39.4%	-60.5%	-$1.21
CRVO	CervoMed Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.01M	-$26.97M	-673.1%	-148.0%	-58.9%	n/a
ACRS	Aclaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.83M	-$64.92M	-829.6%	-63.0%	-58.2%	-$0.53
GOSS	Gossamer Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$48.47M	-$170.37M	-351.5%	n/a	-57.7%	-$0.75
NTHI	Neonc Technologies Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.0K	-$62.15M	n/m	n/a	-51.8%	-$3.20
CELU	Celularity Inc Manufacturing · Year ended 2025-12-31 · USD	$26.55M	-$91.72M	-345.4%	n/a	-51.0%	-$3.59
NAMS	NewAmsterdam Pharma Co N.V. Manufacturing · Year ended 2025-12-31 · USD	$22.50M	-$203.82M	-905.7%	-29.8%	-50.6%	-$1.72
TCRT	Alaunos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.0K	-$4.18M	n/m	-194.0%	-50.0%	-$2.20
LGVN	Longeveron Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.20M	-$22.70M	n/m	-400.1%	-49.9%	-$1.29
MRKR	Marker Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.55M	-$12.16M	-343.0%	-72.4%	-46.2%	-$0.79
ARCT	Arcturus Therapeutics Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$82.03M	-$65.78M	-80.2%	-30.7%	-46.1%	-$2.40
PVCT	Provectus Biopharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$336.1K	-$5.43M	n/m	n/a	-45.5%	-$0.01
CTMX	CytomX Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$76.20M	-$17.37M	-22.8%	-17.5%	-44.8%	n/a
NKTR	Nektar Therapeutics Manufacturing · Year ended 2025-12-31 · USD	$55.23M	-$164.08M	-297.1%	-182.6%	-43.9%	-$9.73
ABVC	Abvc Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$296.0K	-$7.91M	n/m	-71.2%	-41.9%	-$0.39
CLNN	Clene Inc. Manufacturing · Year ended 2025-12-31 · USD	$200.0K	-$26.17M	n/m	n/a	-41.5%	n/a
LYEL	Lyell Immunopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.0K	-$274.45M	n/m	-110.6%	-41.0%	-$16.06
QURE	uniQure N.V. Manufacturing · Year ended 2025-12-31 · USD	$16.10M	-$198.97M	n/m	-100.0%	-40.6%	-$3.46
QUCY	Quantum Cyber N.V. Manufacturing · Year ended 2025-12-31 · USD	$537.1K	-$16.21M	n/m	n/m	-39.9%	-$2.70
CANF	Can-Fite BioPharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$405.0K	-$9.83M	n/m	-175.8%	-39.9%	-$5.97
GOVX	GeoVax Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.49M	-$21.46M	-862.3%	-561.2%	-37.1%	n/a
PRPH	ProPhase Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.34M	-$14.74M	-339.3%	-420.3%	-35.8%	-$1.74
SXTC	China SXT Pharmaceuticals, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.14M	-$6.21M	-545.2%	-20.9%	-34.6%	-$9.13
SIGA	Siga Technologies Inc Manufacturing · Year ended 2025-12-31 · USD	$94.57M	$23.28M	24.6%	11.7%	-31.8%	$0.32
RMTI	Rockwell Medical, Inc. Manufacturing · Year ended 2025-12-31 · USD	$69.26M	-$5.31M	-7.7%	-14.4%	-31.8%	-$0.15
EBS	Emergent BioSolutions Inc. Manufacturing · Year ended 2025-12-31 · USD	$742.90M	$52.60M	7.1%	10.1%	-28.8%	$0.93
MRVI	Maravai Lifesciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$185.74M	-$130.77M	-70.4%	-61.6%	-28.3%	-$0.90
CASIF	CASI Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.71M	-$48.06M	-232.0%	n/a	-27.4%	-$2.59
EMMA	Emmaus Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$12.45M	-$7.49M	-60.2%	n/a	-25.2%	-$0.12
IMNM	Immunome Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.94M	-$212.39M	n/m	-33.5%	-23.2%	-$2.43
AQST	Aquestive Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.55M	-$83.78M	-188.1%	n/a	-22.6%	-$0.78
LFVN	Lifevantage Corp Manufacturing · Year ended 2026-06-30 · USD	$182.59M	$5.07M	2.8%	15.1%	-20.1%	$0.40
INBP	Integrated Biopharma Inc Manufacturing · Year ended 2026-06-30 · USD	$43.87M	-$2.84M	-6.5%	-16.1%	-19.3%	-$0.09
OCUL	Ocular Therapeutix, Inc Manufacturing · Year ended 2025-12-31 · USD	$51.95M	-$265.94M	-511.9%	-40.6%	-18.5%	-$1.42
IRWD	Ironwood Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$296.15M	$24.02M	8.1%	n/a	-15.7%	$0.15
OPK	Opko Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$606.88M	-$225.68M	-37.2%	-17.8%	-14.9%	-$0.30
PYXS	Pyxis Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.86M	-$79.62M	-574.5%	-149.1%	-14.2%	-$1.28
AYTU	Aytu Biopharma, Inc Manufacturing · Year ended 2026-06-30 · USD	$57.57M	-$14.25M	-24.8%	-40.4%	-13.3%	n/a
HCM	HUTCHMED (China) Ltd Manufacturing · Year ended 2025-12-31 · USD	$548.51M	$456.91M	83.3%	36.5%	-13.0%	$0.52
CVSI	CV Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.79M	-$958.0K	-6.9%	-65.3%	-12.2%	-$0.01
CPHI	China Pharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.14M	-$3.19M	-76.9%	-14.0%	-8.5%	-$0.74
AMRN	Amarin Corp PLC Manufacturing · Year ended 2025-12-31 · USD	$213.65M	-$38.80M	-18.2%	-8.4%	-6.5%	-$0.09
LAB	Standard Biotools Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.33M	-$74.90M	-87.8%	-17.7%	-6.2%	-$0.20
JANX	Janux Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$113.62M	n/m	-11.9%	-5.6%	-$1.83
IGC	IGC Pharma, Inc. Manufacturing · Year ended 2025-03-31 · USD	$1.27M	-$7.12M	-560.3%	-112.5%	-5.5%	-$0.09
SPRY	ARS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$84.28M	-$171.30M	-203.3%	-149.9%	-5.5%	-$1.74
ALKS	Alkermes plc. Manufacturing · Year ended 2025-12-31 · USD	$1.48B	$241.66M	16.4%	13.3%	-5.2%	$1.43
PBH	Prestige Consumer Healthcare Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.09B	$190.30M	17.5%	10.1%	-4.3%	$3.91
RCUS	Arcus Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$247.00M	-$353.00M	-142.9%	-55.9%	-4.3%	-$3.29
ENTA	Enanta Pharmaceuticals Inc Manufacturing · Year ended 2025-09-30 · USD	$65.32M	-$81.89M	-125.4%	-126.5%	-3.4%	-$3.84
VTRS	Viatris Inc Manufacturing · Year ended 2025-12-31 · USD	$14.30B	-$3.51B	-24.6%	-23.9%	-3.0%	-$3.00
OGN	Organon & Co. Manufacturing · Year ended 2025-12-31 · USD	$6.22B	$187.00M	3.0%	24.9%	-2.9%	$0.72
ENSC	Ensysce Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.07M	-$10.18M	-200.8%	-316.6%	-2.8%	-$3.98
PRGO	Perrigo Co PLC Manufacturing · Year ended 2025-12-31 · USD	$4.25B	-$1.43B	-33.5%	-48.6%	-2.8%	-$10.29
AMPH	Amphastar Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$719.89M	$98.09M	13.6%	12.4%	-1.7%	$2.03
PFE	Pfizer Inc Manufacturing · Year ended 2025-12-31 · USD	$62.58B	$7.77B	12.4%	9.0%	-1.6%	$1.36
JAGX	Jaguar Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.51M	-$53.58M	-465.4%	n/a	-1.5%	-$22.97
LIFD	Lftd Partners Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.92M	-$24.86M	-67.3%	-196.8%	-1.1%	-$1.68
PBYI	Puma Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$228.37M	$31.11M	13.6%	23.9%	-0.9%	$0.61
MGNX	Macrogenics Inc Manufacturing · Year ended 2025-12-31 · USD	$149.50M	-$74.62M	-49.9%	-134.2%	-0.3%	-$1.18
ARVN	Arvinas, Inc. Manufacturing · Year ended 2025-12-31 · USD	$262.60M	-$80.80M	-30.8%	-18.6%	-0.3%	-$1.14
NWBO	Northwest Biotherapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$1.38M	-$60.16M	n/m	n/a	-0.3%	-$0.04
BMY	Bristol Myers Squibb Co Manufacturing · Year ended 2025-12-31 · USD	$48.19B	$7.05B	14.6%	38.2%	-0.2%	$3.46
GNLX	Genelux Corp Manufacturing · Year ended 2025-12-31 · USD	$8.0K	-$32.15M	n/m	-278.5%	0.0%	-$0.86

Rows per page: 25 50100